CoChat

5-HT2A receptor blockade in patients with schizophrenia treated with risperidone or clozapine: A SPET study using the novel 5-HT2A ligand 1231-5-1-R-91150

Travis, Michael J., Busatto, Geraldo F., Pilowsky, Lyn S., Mulligan, Rachel, Acton, Paul D., Gacinovic, Sveto, Mertens, John, Terrière, Dirk, Costa, Durval C., Ell, Peter J., Kerwin, Robert W. · 1998 · British Journal of Psychiatry
Cited by 69

The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.

Abstract

Background: 5-HT 2A receptor antagonism may be crucial to the action of atypical antipsychotics. Previous work has related 5-HT 2A receptor blockade to clinical efficacy and protection from extrapyramidal side-effects. Method: We developed a SPET imaging protocol for assessing 5-HT 2A receptor binding using the selective ligand 123 1-5-1-R91150. Six healthy volunteers, five clozapine- and five risperidone-treated subjects with DSM–IV schizophrenia were studied. Multi-slice SPET was performed on each subject. Results: Cortex: cerebellum ratios were significantly lower in both clozapine-and risperidone-treated subjects compared with the healthy volunteers in all cortical regions. There was no difference in occupancy between the two drug-treated groups. No correlation was found between the percentage change in the Global Assessment Scale (GAS) and 5-HT 2A receptor binding indices in the drug-treated groups. Conclusions: Clozapine and risperidone potently block 5-HT 2A receptors in vivo. The lack of relationship between receptor binding indices and change in GAS suggests that 5-HT 2A receptor blockade may be unrelated to clinical improvement. Future studies will substantiate this finding by studying 5-HT 2A receptor binding in large groups of patients treated with both typical and novel atypical antipsychotics.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1192/bjp.173.3.236

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Cited by

See all 69

Metadata

Authors
Travis, M. J., Busatto, G. F., Pilowsky, L. S., Mulligan, R., Acton, P. D., Gacinovic, S., Mertens, J., Terrière, D., Costa, D. C., Ell, P. J., & Kerwin, R. W.
Venue
British Journal of Psychiatry
Published
1998-09
Volume
173
Issue
3
Pages
236-241
ISSN
  • 0007-1250 (ISSN-L)
  • 1472-1465
OpenAlex
W2137925486
Cited by
69
References
1
FWCI
3.72
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.